Journal
JOURNAL OF INHERITED METABOLIC DISEASE
Volume 38, Issue 1, Pages 53-64Publisher
WILEY
DOI: 10.1007/s10545-014-9798-0
Keywords
-
Funding
- MetaboHUB [ANR-11-INBS-0010]
- European Community's Seventh Framework Programme (FP7) Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NeurOmics) [2012-305121]
Ask authors/readers for more resources
Lipids are natural substances found in all living organisms. Essential to the integrity of cell membranes, they also have many biological functions linked to energy storage and cell signaling, and are involved in a large number of heterogeneous diseases such as cancer, diabetes, neurological disorders, and inherited metabolic diseases. Lipids are challenging to analyze because of their huge structural diversity and numerous species. Up to now, lipid analysis has been achieved by targeted approaches focusing on selected families and relying on extraction protocols and chromatographic methods coupled to various detectors including mass spectrometry. Thanks to the technological improvements achieved in the fields of chromatography, high-resolution mass spectrometry and bioinformatics, it is possible to perform global lipidomic analyses enabling the concomitant detection, identification and relative quantification of many lipid species belonging to different families. The aim of this review is to focus on mass spectrometry-based methods to perform lipid and lipidomic analyses and on their application to the analysis of cerebrospinal fluid.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available